Psilocybin for Treatment-Resistant Depression

NCT06230757 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder
Anhedonia
Treatment Resistant Depression

Interventions

DRUG: Psilocybin 25mg
DRUG: Placebo (active placebo)

Sponsor

University of Colorado, Denver